Nucleation of calcium oxalate crystals by albumin: Involvement in the prevention of stone formation

Kidney International

Volumn 55, Issue 5, 1999, Pages 1776-1786

  Cerini, Claire ^a,b   Geider, Sophie ^a,b   Dussol, Bertrand ^a,b   Hennequin, Carole ^a,b   Daudon, Michel ^a,b   Veesler, Stéphane ^a,b   Nitsche, Serge ^a,b   Boistelle, Roland ^a,b   Berthézène, Patrice ^a,b   Dupuy, Patricia ^a,b   Vazi, Alain ^a,b   Berland, Yvon ^a,b   Dagorn, Jean Charles ^a,b   Verdier, Jean Michel ^a,b,c  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CNRS   (France)

Author keywords

Aggregation; Albumin; Crystallization; Kidney stones; Lithiasis

Indexed keywords

ALBUMIN; CALCIUM OXALATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; FEMALE; HUMAN; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; STONE FORMATION; TURBIDIMETRY; UROLITHIASIS;

EID: 0032920292     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00426.x     Document Type: Article

References (64)

1. 1. BOYCE Y, KING JS JR: Crystal-matrix interrelations in calculi. J Urol 81:351-358, 1959
2. 2. MORSE RM, RESNICK MI: Urinary stone matrix. J Urol 139:602-606, 1988
3. 3. BOYCE WH, SULKIN NM: Biocolloids of urine in health and calculous disease. III. The mucoprotein matrix of calculi. J Clin Invest 35:1067-1079, 1956
4. 4. BOYCE WH, GARVEY FK: The amount and nature of the organic matrix in urinary calculi: A review. J Urol 76:213-227, 1956
5. 5. KEUTEL HJ, HERMANN G, LICHT W: Immunoelektrophorestiche untersuchungen über serumidentischen anteil der harnkolloide und ihre bedeutung bei der harnsteinbildung. Clin Chim Acta 4:665-673, 1959
6. 6. SUGIMOTO T, FUNAE HY, RUBBEN H, NISHIO S, HAUTMANN R, LUTZEYER W: Resolution of proteins in the kidney stone matrix using high-performance liquid chromatography. Eur Urol 2:334-340, 1985
7. 7. FRAIJ BM: Separation and identification of urinary proteins and stone-matrix proteins by mini-slab sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Clin Chem 35:658-662, 1989
8. 8. JONES WT, RESNICK MI: The characterization of soluble matrix proteins in selected human renal calculi using two-dimensional polyacrylamide gel electrophoresis. J Urol 144:1010-1014, 1990
9. 9. SPECTOR AR, GRAY A, PRIEN EL JR: Kidney stone matrix: Differences in acidic protein composition. Invest Urol 13:387-389, 1976
10. 10. BUSCEMI PJ, WARPEHOSKI MH, FINLAYSON B, GOLBERG EP: Distribution of organic matrix in calcium oxalate renal calculi. Calcif Tissue Int 33:211-222, 1981
11. 11. LIAN JB, PRIEN EL JR, GLIMCHER MJ JR, GALLOP PM: The presence of protein bound gamma-carboxyglutamic acid in calcium containing renal calculi. J Clin Invest 59:1151-1157, 1977
12. 12. LEAL JJ, FINLAYSON B: Adsorption of naturally occurring polymers onto calcium oxalate crystals surfaces. Invest Urol 14:278-283, 1977
13. 13. DOYLE IR, RYALL RL, MARSHALL VR: Inclusion of proteins into calcium oxalate crystals precipitated from human urine: A highly selective phenomenon. Clin Chem 37:1589-1594, 1991
14. 14. BOYCE WH: Organic matrix of human urinary concretions. Am J Med 45:673-683, 1968
15. 15. DUSSOL B, GEIDER S, LILOVA A, LÉONETTI F, DUPUY P, DAUDON M, BERLAND Y, DAGORN JC, VERDIER JM: Analysis of the soluble organic matrix of five different kidney stones: Evidence for a specific role of albumin in the constitution of the stone protein matrix. Urol Res 23:45-51, 1995
16. 16. ATMANI F, GLENTON PA, KHAN SR: Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201-207, 1998
17. 17. EDYVANE KA, HIBBERD CM, HARNETT RM, MARSHALL VR, RYALL RL: Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine. Clin Chim Acta 167:329-338, 1987
18. 18. WORCESTER EM: Urinary calcium oxalate crystal growth inhibitors. J Am Soc Nephrol 5:S46-S53, 1994
19. 19. HENNEQUIN C, LALANNE V, DAUDON M, LACOUR B, DRUEKE T: A new approach to studying inhibitors of calcium oxalate crystal growth. Urol Res 21:101-108, 1993
20. 20. MELIK DH, FOGLER HS: Turbidimetric determination of particle size distribution of colloidal systems. J Coll Interfer Sci 92:161-180, 1983
21. 21. HESS B, NAKAGAWA Y, COE FL: Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99-F106, 1989
22. 22. LEONETTI F, DUSSOL B, BERTHÉZÈNE P, THIRION X, BERLAND Y: Dietary and urinary risk factors for stones in idiopathic calcium stone formers compared with healthy subjects. Nephrol Dial Transplant 13:617-622, 1998
23. 23. CARTER DC, HE XM, MUNSON SH, TWIGG PD, GERNERT KM, BROOM MB, MILLER TY: Three dimensional structure of human serum albumin. Science 244:1195-1198, 1989
24. 24. HE XM, CARTER DC: Atomic structure and chemistry of human serum albumin. Nature 358:209-215, 1992
25. 25. WERNESS PG, BERGERT JH, SMITH LH: Crystalluria. J Cryst Growth 53:166-181, 1981
26. 26. FÜREDI-MILHOFER H, TUNIK L, BLOCH R, GARTI N: The influence of surfactants on the crystallization of calcium oxalate hydrates. Mol Cryst Liq Cryst 248:199-206, 1994
27. 27. PETERS T JR: Serum albumin. Adv Protein Chem 37:161-245, 1985
28. 28. HEMMINGSEN L, SKAARUP P: The 24-hour excretion of plasma proteins in the urine of apparently healthy subjects. Scand J Clin Lab Invest 35:347-353, 1975
29. 29. CAMPBELL AA, EBRAHIMPOUR A, PEREZ L, SMESKO SA, NANCOLLAS GH: The dual role of polyelectrolytes and proteins as mineralization promoters and inhibitors of calcium oxalate monohydrate. Calcif Tissue Int 45:122-128, 1989
30. 30. KAVANAGH JP: Methods for the study of calcium oxalate crystallization and their application to urolithiasis research. Scanning Microsc 6:685-704, 1992
31. 31. KAVANAGH JP, NISHIO S, GARSIDE J, BLACKLOCK NJ: Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: Comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer. J Urol 149:614-617, 1993
32. 32. BERRY JP, GALLE P, HENOC P, LAGRUE G: Crystalloid nature of mineral deposits in Bowman's capsule of the human glomerulus: Study by x-ray microanalysis and electron microdiffraction. Pathol Biol 25:37-41, 1977
33. 33. KHAN SR, FINLAYSON B, HACKETT RL: Histologic study of the early events in oxalate induced intranephronic calculosis. Invest Urol 17:199-202, 1979
34. 34. SARIG S, KAHANA F: On the association between sparingly soluble carbonates and polyelectrolytes. J Cryst Growth 35:145-152, 1976
35. 35. ROBERTSON WG, PEACOCK M, NORDIN BEC: Calcium crystalluria in recurrent renal-stone formers. Lancet 2:21-24, 1969
36. 36. ROBERTSON WG, PEACOCK M: Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. Clin Sci 43:499-506, 1972
37. 37. CRASSWELLER PO, BRANDES L, KATIRTZOGLOU A, OREOPOULOS DG: Studies of crystalluria in recurrent calcium lithiasis. Can J Surg 22:527-529, 1979
38. 38. ROBERTSON WG, SCURR DS, BRIDGE CM: Factors influencing the crystallization of calcium oxalate in urine-critique. J Cryst Growth 53:182-194, 1981
39. 39. AZOURY R, ROBERTSON WG, GARSIDE J: Observations on in vitro and in vivo calcium oxalate crystalluria in primary calcium stone formers and normal subjects. Br J Urol 59:211-213, 1987
40. 40. GUTHROW CE, MORRIS MA, DAY JF, THORPE SR, BAYNES JW: Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 76:4258-4261, 1979
41. 41. BRANDT J, ANDERSSON LO: Heat denaturation of human serum albumin: Migration of bound fatty acids. Int J Pept Protein Res 8:33-37, 1976
42. 42. FOSTER JF: Some aspects of the structure and conformational properties of serum albumin, in Albumin Structure, Function and Uses, edited by Rosenoer VM, Oratz M, Rothschild MA, Oxford, Pergamon Press, 1977, pp 53-84
43. 43. ROGERS JS, STALL RE, BURKE MJ: Low-temperature conditioning of the ice nucleation active bacterium, Erwinia herbicola. Cryobiology 24:270-279, 1987
44. 44. WETZEL R, BECKER M, BEHLKE J, BILLWITZ H, BÖHM S, EBERT B, HAMANN H, KRUMBIEGEL J, LASSMANN G: Temperature behaviour of human serum albumin. Eur J Biochem 104:469-478, 1980
45. 45. SUSUKI E, YASUDA K, TAKEDA N, SAKATA S, ERA S, KUWATA K, SOGAMI M, MIURA K: Increased oxidized form of human serum albumin in patients with diabetes. Diabetes Res Clin Pract 18:153-158, 1992
46. 46. KUCK JR, YU NT, ASKREN CC: Total sulfhydryl by raman spectroscopy in the intact lens of several species: Variations in the nucleus and along the optical axis during aging. Exp Eye Res 34:23-37, 1982
47. 47. ERA S, KUWATA K, IMAI H, NAKAMURA K, HAYASHI T, SOGAMI M: Age-related change in redox of human serum albumin. Biochim Biophys Acta 1247:12-16, 1995
48. 99mTc-labelled macroaggegrated albumin-Part 1: Aggregation of non-mercaptalbumin and its conformation. Nucl Med Biol 20:643-648, 1993
49. 49. RYALL RL, HARNETT RM, HIBBERD CM, EDYVANE KA, MARSHALL VR: Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in indiluted human urine. Urol Res 19:181-188, 1991
50. 50. HESS B, MEINHARDT U, ZIPPERLE L, GIOVANOLI R, JAEGER P: Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: Impact of various modifiers. Urol Res 23:231-238, 1995
51. 51. GROVER PK, MORITZ RL, SIMPSON RJ, RYALL RL: Inhibition of growth and aggregation of calcium oxalate crystals in vitro: A comparison of four human proteins. Eur J Biochem 253:637-644, 1998
52. 52. ROBERTSON WG, PEACOCK M, MARSHALL RW, MARSHALL DH, NORDIN BE: Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med 294:249-252, 1976
53. 53. FINLAYSON B: Physicochemical aspects of urolithiasis. Kidney Int 13:344-360, 1978
54. 54. BERLAND Y, OLMER M, BOISTELLE R, BARLATIER A: Respective effect of calcium and oxalate on calcium oxalate crystallization in the urine. Nephrology 5:175-179, 1984
55. 55. BRIEN G, SCHUBERT G, BICK C: 10,000 Analyses of urinary calculi using x-ray diffraction and polarizing microscopy. Eur Urol 8:251-256, 1982
56. 56. MANDEL NS, MANDEL GS: Physicochemistry of urinary stone formation, in Renal Stone Disease, edited by Pak CYC, Boston, Martinus Nijhoff, 1987, pp 1-24
57. 57. DAUDON M, DONSIMONI R, HENNEQUIN C, FELLAHI S, LE MOEL G, PARIS M, TROUPEL S, LACOUR B: Sex- and age-related composition of 10,617 calculi analyzed by infrared. Urol Res 23:319-326, 1995
58. 58. IWATA H, LIO S, NISHIO S, TAKEUCHI M: Architecture of mixed calcium oxalate dihydrate and monohydrate stones. Scanning Microsc 6:231-238, 1992
59. 59. EDYVANE KA, RYALL RL, MARSHALL VR: The influence of serum and serum proteins on calcium oxalate crystal growth and aggregation. Clin Chim Acta 157:81-88, 1986
60. 60. WILLIAMS RJP: Calcium chemistry and its relation to protein binding, in Calcium-Binding Proteins and Calcium Function, edited by Wasserman RH, Corradino RA, Carafoli E, Kretsinger RH, MacLennan DH, Siegel FL, New York, Elsevier, 1977, pp 3-12
61. 61. GREENFIELD EM, WILSON DC, CRENSHAW MA: Ionotropic nucleation of calcium carbonate by molluscan matrix. Am Zool 24:925-932, 1984
62. 62. PERL-TREVES D, ADDADI L: A structural approach to pathological crystallizations. Gout: the possible role of albumin in sodium urate crystallization. Proc R Soc Land B 235:145-159, 1988
63. 63. STRAWICH E, GLIMCHER MJ: Tooth 'enamelins' identified mainly as serum proteins: Major 'enamelin' is albumin. Eur J Biochem 191:47-56, 1990
64. 64. MURRAY FE, SMITH BF: Non-mucin proteins in the matrix of human cholesterol gallstones. Scand J Gastroenterol 26:717-723, 1991